Recurrent facial herpes simplex. Treatment with active paramunization
Schwarz, G.; Stickl, H.
Fortschritte der Medizin 99(19): 722-727
1981
ISSN/ISBN: 0015-8178 PMID: 6263771 Document Number: 172749
132 patients with herpes simplex manifestations were treated with PIND, a heterologous pox-virus-antigen, that stimulates T-cells and macrophages. The shortening of duration of the disease, the subsequent relief from pain and the decrease in frequency of recurrence was proven.
Document emailed within 1 workday
Related Documents
Nouri, K.; Ricotti, C.A.; Bouzari, N.; Chen, H.; Ahn, E.; Bach, A. 2006: The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide Journal of Drugs in Dermatology: Jdd 5(2): 182-185Arone di Bertolino, R. 1981: Psychosomatic treatment of recurrent herpes simplex Minerva Medica 72(19): 1207-1212
Colette Smit, C.P.,A.M.,J.T.,J.S.,B.B.,R.C.andN.H.T.M.D. 2007: Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and Hiv over time (19842003) European Journal of Epidemiology 22(12): 937-944
Khamaganova, A.V.; Zhukova, I.K.; Shekrota, A.G. 1980: Soviet-made interferon in the treatment of recurrent herpes simplex Vestnik Dermatologii i Venerologii 4: 53-55
McCune, M.A.; Perry, H.O.; Muller, S.A.; O'Fallon, W.M. 1984: Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride Cutis 34(4): 366-373
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Prober, C.G.; Sullender, W.M.; Yasukawa, L.L.; Au, D.S.; Yeager, A.S.; Arvin, A.M. 1987: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections New England Journal of Medicine 316(5): 240-244
Kapur, T.R. 1977: Recurrent Erythema Multiforme Associated with Relapsing Herpes Simplex Indian Journal of Dermatology Venereology and Leprology 43(3): 164-165
Ichihashi, M.; Nagai, H.; Matsunaga, K. 2004: Sunlight is an important causative factor of recurrent herpes simplex Cutis 74(5 Suppl): 14-18
Miller, C.S.; Foulke, C.N. 1984: Use of lysine in treating recurrent oral herpes simplex infections General Dentistry 32(6): 490-493
De Stefano, A.; Neri, G.; Kulamarva, G. 2009: Delayed facial nerve paralysis post middle ear surgery: herpes simplex virus activation B-Ent 5(1): 47-50
Harmenberg, J.; Spruance, S. 2010: Recurrent herpes simplex labialis infections. Possible prevention with a new therapeutic regimen Lakartidningen 107(34): 1918-1922
Suárez, M.; Labbé, V.; Saavedra, T.; Manuel Ojeda, J. 1988: Viral types of herpes simplex associated with primary and recurrent genital infections in Chile Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 105(1): 13-19
Maeglin, B. 1987: Herpes simplex. Oral and peroral infection with Herpes simplex virus Schweizer Monatsschrift für Zahnmedizin 97(12): 1532-1536
Hinokuma, R. 1979: The effect of collagenase inhibitor in herpes simplex keratitis. Part I. the diagnosis of herpes simplex disciformis keratitis by fluorescent antibody technique Nippon Ganka Gakkai Zasshi 83(6): 507-512
Epstein, S.P.; Fisher, E.M.; Sternberg, G.J.; Franklin, W.; Gordon, R.; Ho, J.J.; Asbell, P.A. 2001: Recurrent ocular herpes simplex keratitis following excimer laser photorefractive keratectomy in a rabbit model Clao Journal: Official Publication of the Contact Lens Association of Ophthalmologists Inc 27(2): 94-99
Saito, H. 1983: Immunologic studies of herpes simplex keratitis. Characterization of immune spleen cells in herpes simplex keratitis in mice Nippon Ganka Gakkai Zasshi 87(11): 1010-1016
Pinegin, B.V.; Butakov, A.A.; Buraia, T.L.; Saidov, M.Z.; Makarova, S.A.; Alkeeva, A.B. 1992: Comparative analysis of functional activity of peripheral blood phagocytes in HIV-infected patients and in those with recurrent herpes simplex Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1992(9-10): 32-36
Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326